No definition available.
Malignant neoplasm of penis, excluding all cancers (controls excluding all cancers)
C3_PENIS_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly males |
226837 |
2. Check conditionsNone |
226837 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
217 |
4. Check minimum number of eventsNone |
217 |
5. Include endpointsNone |
217 |
6. Filter based on genotype QC (FinnGen only) |
217 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of penis, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 217 | - | 217 |
| Unadjusted period prevalence (%) | 0.10 | - | 0.10 |
| Median age at first event (years) | 66.87 | - | 66.87 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 112
- Matched controls
- 1120
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C60.1
ICD-10 Finland
Malignant neoplasm: Glans penis
+∞
94.6
77
*
C60.9
ICD-10 Finland
Malignant neoplasm: Penis, unspecified
+∞
57.3
50
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
52.2
46
*
8070/3-C60.9
ICD-O-3
Squamous cell carcinoma, NOS, of penis, NOS
+∞
51.0
45
*
KGB00
NOMESCO Finland
Biopsy of penis
+∞
38.8
35
*
KGC00
NOMESCO Finland
Partial amputation of penis
+∞
38.8
35
*
8070/3-C60.1
ICD-O-3
Squamous cell carcinoma, NOS, of glans penis
+∞
37.6
34
*
C60.0
ICD-10 Finland
Malignant neoplasm: Prepuce
+∞
35.3
32
*
D40.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other male genital organs
+∞
34.1
31
*
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
87.0
33.5
36
6
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
+∞
30.6
28
*
JN4BD
NOMESCO Finland
Extensive body CT
27.6
25.5
35
18
KGD00
NOMESCO Finland
Partial excision of glans penis
+∞
23.8
22
*
KGD05
NOMESCO Finland
Partial excision of body of penis
+∞
22.7
21
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
21.5
20
*
130
Kela drug reimbursment
Malignant tumour
+∞
21.5
20
*
KGH10
NOMESCO Finland
Operation for phimosis
18.9
21.3
33
24
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
20.4
19
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
19.3
18
*
N48.1
ICD-10 Finland
Balanoposthitis
17.3
18.2
29
22
C60.2
ICD-10 Finland
Malignant neoplasm: Body of penis
+∞
18.2
17
*
H02AB02
ATC
dexamethasone; systemic
99.2
16.0
17
*
KGD96
NOMESCO Finland
Other partial excision of penis
+∞
16.0
15
*
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
12.6
15.9
29
30
JN4AD
NOMESCO Finland
Body CT examination
22.4
15.4
22
12
C60.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of penis
+∞
14.9
14
*
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
61.5
14.2
16
*
116
Kela drug reimbursment
Prostate cancer
+∞
13.8
13
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
13.8
13
*
C77.4
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
+∞
13.8
13
*
TKD00
NOMESCO Finland
Dilatation of urethra
145.5
12.7
13
*
WX402
NOMESCO Finland
General anaesthesia
6.4
12.6
36
77
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
5.7
12.2
39
96
WX408
NOMESCO Finland
General anesthesy, balanced
4.8
11.7
46
141
XKD00
NOMESCO Finland
Uroflowmetry
4.8
11.5
45
137
UKC02
NOMESCO Finland
Cystoscopy
4.8
11.4
44
132
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
9.7
11.3
23
29
WZC30
NOMESCO Finland
Teaching
7.9
11.2
26
41
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
+∞
10.6
10
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
10.6
10
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.2
9.7
43
145
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
9.5
9
*
KGD10
NOMESCO Finland
Destruction of lesion of penis
+∞
9.5
9
*
KGC10
NOMESCO Finland
Total amputation of penis
+∞
9.5
9
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
9.5
9
*
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
9.5
9
*
Z51.5
ICD-10 Finland
Palliative care
15.8
9.0
14
10
ZZA00
NOMESCO Finland
Split skin graft
15.8
9.0
14
10
KDH10
NOMESCO Finland
Meatoplasty of urethra
54.3
8.8
10
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
6.1
8.7
24
48
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
97.0
8.5
9
*
WX240
NOMESCO Finland
Penis blockade
97.0
8.5
9
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.7
8.5
25
54
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
8.4
8
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
8.4
8
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
8.4
8
*
TKC20
NOMESCO Finland
Catheterisation of bladder
6.4
8.0
21
39
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
16.6
7.9
12
8
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
10.0
7.8
15
17
R33
ICD-10 Finland
Retention of urine
5.1
7.8
25
60
D07.4
ICD-10 Finland
Carcinoma in situ: Penis
85.4
7.5
8
*
N48.8
ICD-10 Finland
Other specified disorders of penis
85.4
7.5
8
*
JN4CD
NOMESCO Finland
Very extensive body CT
17.2
7.4
11
7
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
7.4
7
*
8051/3-C60.9
ICD-O-3
Verrucous carcinoma, NOS, of penis, NOS
+∞
7.4
7
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
7.4
7
*
L02BB03
ATC
bicalutamide; oral
+∞
7.4
7
*
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
+∞
7.4
7
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
7.4
7
*
D29.0
ICD-10 Finland
Benign neoplasm: Penis
+∞
7.4
7
*
WX320
NOMESCO Finland
Spinalanesthesy
3.5
7.1
37
137
A03FA01
ATC
metoclopramide; systemic, rectal
5.7
7.1
20
41
J01DB01
ATC
cefalexin; oral
3.5
6.5
95
689
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
19.3
6.4
9
5
Y04
ICPC
Penis symptom/complaint other
28.4
6.3
8
*
8070/3-C60.0
ICD-O-3
Squamous cell carcinoma, NOS, of prepuce
+∞
6.3
6
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
N35.9
ICD-10 Finland
Urethral stricture, unspecified
13.5
6.2
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
58
44
17.63
63.92
1.8
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
64
99
8.75
42.24
1.5
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
112
372
5.16
32.20
3.5
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
135
619
4.13
23.26
6.7
3.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
90
334
3.90
20.64
3.5
2.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
63
187
4.34
19.64
2.1
1.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
103
430
3.66
19.61
3.1
2.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
29
45
7.28
18.43
1.9
1.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
157
894
3.73
17.64
6.5
3.6
e6/l
18.3
619.3
—
7
15
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
81
326
3.37
15.75
3.2
2.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
96
457
2.97
13.64
6.7
4.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
62
238
3.25
12.71
2.4
1.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
87
445
2.59
10.17
5.0
2.8
e6/l
33.2
241.7
0.81
73
346
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
61
263
2.84
9.96
1.9
1.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
98
537
2.50
9.83
5.3
2.8
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
161
1117
2.71
9.60
13.0
5.4
u/l
83.3
75.3
1.67
151
1029
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
25
63
4.35
9.34
2.2
1.9
ug/l
2.9
2.2
0.12
18
56
(3018095) Leukocytes [#/volume] in Urine
92
501
2.45
9.23
5.4
3.1
e6/l
652.8
79.5
0.52
77
369
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
115
693
2.40
9.18
10.8
6.0
mmol/l
1.2
1.2
1.04
96
590
(3003694) ABO and Rh group [Type] in Blood
72
354
2.55
8.96
1.6
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
54
4.42
8.48
2.5
2.4
u/ml
0.3
0.3
0.91
13
27
(3024561) Albumin [Mass/volume] in Serum or Plasma
107
645
2.30
8.30
8.3
3.7
g/l
34.0
35.1
1.33
99
587
(36304419) Bacteria [Presence] in Urine
73
378
2.40
8.00
3.9
2.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
77
409
2.37
7.96
4.3
2.6
e6/l
0.4
0.4
0.03
61
302
(3049717) Cytology report of Urine Cyto stain
23
62
4.03
7.86
3.3
1.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
104
639
2.21
7.49
10.1
5.5
mmol/l
1.2
1.2
1.02
96
564
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
52
239
2.55
7.30
4.1
2.7
e6/l
0.8
0.7
0.13
34
138
(3032080) INR in Blood by Coagulation assay
109
688
2.17
7.28
10.8
11.4
inr
1.3
1.4
0.51
28
190
(3013650) Neutrophils [#/volume] in Blood by Automated count
118
770
2.17
7.22
16.3
6.3
e9/l
4.4
4.5
0.13
107
678
(42870588) Differential panel, method unspecified - Blood
81
460
2.21
7.00
8.6
5.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
38
159
2.69
6.40
4.3
3.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
137
994
2.03
5.81
6.5
3.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
50
254
2.26
5.52
4.0
2.6
e6/l
1.4
1.0
0.41
33
154
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
30
120
2.74
5.49
1.6
1.5
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
33
141
2.58
5.31
6.6
6.2
mmol/l
1.1
1.5
2.91
33
135
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
26
98
2.88
5.30
1.8
1.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
42
204
2.31
5.13
4.3
2.5
%
18.5
24.6
2.40
37
176
(3026782) Osmolality of Urine
54
293
2.12
5.04
3.6
2.3
mosm/kgh2o
579.3
611.5
0.47
47
231
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
39
187
2.32
4.90
1.7
1.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
65
382
2.00
4.88
8.7
3.8
ph
7.4
7.4
0.63
14
60
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
20
68
3.14
4.86
2.0
1.6
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
95
640
1.86
4.71
9.8
5.6
%
8.8
9.1
0.43
90
594
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
23
87
2.84
4.66
8.1
8.6
mmol/l
24.0
24.7
0.56
23
75
(3006504) Eosinophils/100 leukocytes in Blood
94
635
1.85
4.59
9.7
5.4
%
3.2
3.2
0.01
89
587
(46235355) HIV 1 and 2 tests - Meaningful Use set
34
160
2.33
4.45
1.6
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
62
369
1.95
4.44
4.1
2.9
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
92
623
1.83
4.42
9.7
5.3
%
0.6
0.6
0.28
87
580
(3002030) Lymphocytes/100 leukocytes in Blood
95
652
1.81
4.35
9.6
5.5
%
22.1
25.7
1.85
89
603
(3021879) Hepatitis B virus core Ab [Presence] in Serum
20
74
2.88
4.22
1.1
1.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
94
652
1.78
4.10
9.2
5.3
%
61.1
58.4
1.08
88
605
(3019225) pH of Specimen
32
152
2.30
4.09
6.0
3.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
28
126
2.40
4.04
1.7
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
96
674
1.76
3.99
6.2
4.3
estimate
0.0
0.0
0.00
18
118
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
17
60
2.99
3.89
1.9
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
11
29
3.94
3.85
1.7
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
29
3.94
3.85
1.3
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
36
187
2.11
3.71
1.8
1.8
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
98
705
1.71
3.65
9.6
5.3
e9/l
0.3
0.2
0.39
86
618
(3001604) Monocytes [#/volume] in Blood
95
683
1.70
3.52
9.3
5.2
e9/l
0.7
0.6
0.82
81
590
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
20
82
2.59
3.50
8.9
9.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
96
693
1.69
3.49
4.3
3.2
estimate
0.0
0.0
0.00
17
109
(3006315) Basophils [#/volume] in Blood
95
685
1.69
3.47
9.3
5.2
e9/l
0.0
0.0
0.02
80
600
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
37
3.37
3.39
1.6
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
94
679
1.68
3.39
4.4
3.2
estimate
0.0
0.0
0.00
18
113
(3019198) Lymphocytes [#/volume] in Blood
96
698
1.67
3.37
9.3
5.3
e9/l
1.8
1.8
0.01
83
613
(3021589) Normoblasts [#/volume] in Blood
89
635
1.68
3.35
18.4
8.5
e9/l
0.0
0.0
0.82
73
520
(3015377) Calcium [Moles/volume] in Serum or Plasma
67
444
1.74
3.30
8.0
2.1
mmol/l
2.4
2.3
0.62
58
358
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
7
8.77
3.28
1.2
1.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
7
8.77
3.28
1.2
1.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
28
3.70
3.23
1.8
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
28
3.70
3.23
1.5
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
8
15
5.49
3.22
1.6
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
8
15
5.49
3.22
1.6
1.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
8
15
5.49
3.22
1.6
1.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
8
15
5.49
3.22
1.6
1.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
8
15
5.49
3.22
1.6
1.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
8
15
5.49
3.22
1.6
1.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
21
92
2.42
3.22
1.7
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
9
20
4.65
3.15
1.9
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
176
1520
1.84
3.09
29.9
13.5
mg/l
33.9
27.1
1.52
163
1180
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
8
7.67
3.07
1.0
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
28
143
2.10
3.02
9.6
7.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
67
454
1.69
3.01
3.4
2.8
u/l
29.8
37.6
1.50
62
428
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
77
545
1.64
2.92
4.6
3.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
13
5.52
2.89
1.9
1.6
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
7
13
5.52
2.89
2.4
1.6
u/ml
163.8
2.8
—
7
13
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
23
4.04
2.80
1.0
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
52
335
1.73
2.79
2.5
1.8
nmol/l
1266.6
1215.5
0.10
41
262
(3004451) EKG impression Narrative
5
6
8.49
2.76
1.2
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
10
6.13
2.71
1.0
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
19
4.33
2.70
1.3
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
24
3.86
2.70
1.0
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
43
2.90
2.69
1.2
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
25
3.71
2.60
1.3
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
12
44
2.83
2.59
3.3
1.3
—
1.3
—
0
6
(3027945) Reticulocytes/100 erythrocytes in Blood
36
213
1.83
2.56
6.2
1.8
%
1.7
1.7
0.09
36
190
(3015736) pH of Urine
74
533
1.59
2.56
4.4
3.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
7
7.28
2.56
1.2
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
7
7.28
2.56
1.2
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
10
34
3.03
2.44
1.2
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
22
3.73
2.39
1.9
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
17
4.22
2.38
1.9
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
48
316
1.67
2.36
10.7
4.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
23
3.57
2.29
1.0
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
34
205
1.78
2.28
7.8
6.5
mmol/l
-0.1
1.1
0.82
29
149
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
57
397
1.59
2.24
2.4
2.1
mg/l
3.4
2.9
0.65
50
328
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
164
1434
1.59
2.24
27.1
12.2
ml/min/173m2
76.3
76.3
0.00
144
1178
(3013512) EKG study
70
513
1.54
2.20
5.0
4.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
9
30
3.08
2.17
1.9
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
10
37
2.78
2.13
1.7
1.6
—
0.2
—
0
13
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
10
5.09
2.08
1.6
1.4
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
15
4.08
2.05
1.8
1.3
ug/l
10.5
15.8
—
6
15
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
21
3.41
1.98
1.3
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
16
3.82
1.95
6.0
4.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
180
1628
1.62
1.92
31.7
16.8
mmol/l
4.0
4.0
0.08
175
1573
(3017181) Myelocytes/100 leukocytes in Blood
20
109
1.92
1.84
3.5
4.1
%
0.9
0.8
—
10
34
(3021440) Promyelocytes/100 leukocytes in Blood
19
103
1.93
1.78
3.6
4.2
%
0.2
0.1
—
9
30
(3002385) Erythrocyte distribution width [Ratio]
138
1191
1.44
1.77
32.8
15.9
%
14.2
13.7
2.91
138
1156
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
9
36
2.56
1.76
3.3
2.6
mg/l
2.1
1.8
—
9
31
(3013707) Erythrocyte sedimentation rate by Westergren method
128
1091
1.42
1.76
4.6
3.8
mm/h
17.9
11.7
2.83
116
992
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
13
3.91
1.72
1.8
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
40
273
1.57
1.70
7.1
2.0
mmol/l
2.5
2.4
2.39
34
231
(1616796) Gas panel - Central venous blood
8
31
2.64
1.67
4.5
4.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
19
3.22
1.67
1.2
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
19
3.22
1.67
1.3
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
8
32
2.56
1.61
1.0
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
8
32
2.56
1.61
1.0
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
26
2.75
1.59
2.3
2.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
20
3.05
1.59
1.0
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
15
3.39
1.53
1.8
1.7
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
7
27
2.64
1.53
2.3
2.5
mmol/l
105.4
105.2
—
7
27
(3041354) Potassium [Moles/volume] in Venous blood
7
27
2.64
1.53
2.3
2.5
mmol/l
3.9
4.2
—
7
27
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
6
21
2.91
1.51
5.3
5.9
mg/l
10.6
11.2
—
6
21
(4146454)
6
21
2.91
1.51
2.3
3.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
45
324
1.49
1.51
4.0
3.6
kg/l
1.0
1.0
0.13
15
50
(3020630) Protein [Mass/volume] in Serum or Plasma
21
125
1.75
1.50
4.3
1.9
g/l
68.1
67.2
0.20
21
109
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
21
125
1.75
1.50
8.3
3.8
mmol/l
0.7
1.8
0.78
15
94
(3044889) 12 lead EKG panel
130
1130
1.38
1.48
4.1
4.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
11
52
2.17
1.47
6.2
2.5
g/l
0.3
0.3
—
6
20
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
16
3.17
1.44
2.2
1.9
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
6
22
2.77
1.44
1.3
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
17
96
1.84
1.43
3.9
4.3
%
0.0
0.0
—
7
25
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
23
2.65
1.37
1.5
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
174
1599
1.45
1.35
26.7
13.0
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
178
1643
1.46
1.34
34.1
15.9
umol/l
97.6
90.4
0.80
178
1643
(40761535) Cells panel - Urine sediment
22
138
1.66
1.32
4.9
3.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
140
1244
1.35
1.31
7.2
3.9
ug/l
30.5
2.1
0.65
127
1103
(3004588) Protein electrophoresis panel - Serum or Plasma
17
99
1.78
1.31
2.5
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
24
2.54
1.31
1.7
1.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
11
55
2.05
1.29
2.9
2.3
u/l
38.9
36.2
0.16
11
49
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13
70
1.91
1.27
2.1
4.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
81
667
1.34
1.26
2.2
2.0
pmol/l
90.9
91.2
0.02
48
393
(3022145) Colonoscopy Study observation
20
124
1.68
1.26
1.7
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
10
49
2.09
1.24
5.0
4.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
13
71
1.88
1.22
2.9
2.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
52
401
1.39
1.21
1.7
1.5
nmol/l
17.0
18.8
0.55
47
343
(3051387) C reactive protein [Mass/volume] in Capillary blood
7
32
2.23
1.09
3.7
3.8
mg/l
62.3
24.4
—
7
26
(3009445) Proteinase 3 Ab [Units/volume] in Serum
12
67
1.84
1.07
1.0
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
16
98
1.68
1.06
2.4
4.3
%
0.3
0.2
—
6
25
(3005322) IgE [Units/volume] in Serum or Plasma
13
75
1.78
1.05
1.2
1.3
u/ml
1216.5
235.3
0.50
13
68
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
22
2.30
1.04
12.8
4.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
7
34
2.09
1.04
6.9
1.2
u/l
20.7
13.7
—
7
29
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
71
589
1.31
1.02
3.4
3.2
ng/l
5727.8
1719.0
1.05
62
505
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
35
2.03
1.01
2.0
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
11
61
1.85
1.00
1.1
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
26
183
1.48
0.99
2.0
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
23
2.20
0.98
1.2
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
181
1702
1.38
0.98
41.9
19.6
e9/l
234.4
228.1
0.58
176
1640
(3045414) Leukocytes [Presence] in Urine
9
50
1.83
0.98
1.6
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
13
77
1.73
0.97
5.5
3.6
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
181
1703
1.38
0.97
41.8
19.6
e12/l
4.3
4.6
6.54
176
1638
(3010813) Leukocytes [#/volume] in Blood
181
1703
1.38
0.97
41.9
19.6
e9/l
7.4
6.9
2.02
175
1638
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
16
102
1.61
0.93
1.8
2.1
u/l
28.2
36.6
0.55
11
86
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
16
102
1.61
0.93
1.4
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
6
28
2.17
0.92
2.5
2.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
174
1632
1.33
0.91
15.9
8.8
u/l
26.9
29.3
0.82
164
1552
(3001122) Ferritin [Mass/volume] in Serum or Plasma
66
551
1.28
0.90
4.2
2.6
ug/l
228.5
191.0
0.36
60
496
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
29
2.10
0.90
2.5
1.8
—
—
—
0
0
(3000492) Spirometry study
19
129
1.52
0.87
2.2
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
31
1.96
0.85
1.5
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
87
758
1.25
0.83
2.0
2.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
16
107
1.53
0.78
9.9
3.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
109
978
1.23
0.78
3.8
3.2
u/l
70.0
54.8
0.90
102
907
(3009542) Hematocrit [Volume Fraction] of Blood
146
1352
1.24
0.77
24.7
14.3
%
38.0
40.4
1.40
91
878
(40768797) Stomach Pathology biopsy report
24
177
1.40
0.74
1.2
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
38
304
1.30
0.71
1.4
1.7
mg/l
1.2
1.3
0.12
32
234
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
29
223
1.35
0.71
5.1
4.9
%
29.4
30.3
0.18
21
148
(3042631) Mycobacterium sp identified in Specimen
5
26
1.94
0.71
4.2
2.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
41
1.73
0.70
1.0
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
11
69
1.63
0.70
1.1
1.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
42
1.69
0.69
1.9
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
42
1.69
0.69
1.9
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
28
1.80
0.66
1.2
2.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
28
1.80
0.66
2.6
2.0
pg
31.2
34.6
—
5
28
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
13
188
0.67
0.66
1.1
1.2
u/ml
0.9
9.7
—
5
72
(3021788) Differential panel - Synovial fluid
5
30
1.68
0.62
1.2
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
46
543
0.81
0.61
3.1
3.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.0
—
2.0
—
0
7
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
149
1574
0.83
0.59
4.7
5.3
mmol/l
2.6
2.6
0.05
132
1428
(3026493) Urate [Moles/volume] in Serum or Plasma
54
464
1.22
0.57
3.7
2.6
umol/l
14261.6
8921.3
0.19
47
405
(3028626) Oxygen [Partial pressure] in Capillary blood
6
37
1.64
0.56
2.8
2.4
kpa
7.4
7.9
—
6
31
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
41
345
1.23
0.53
3.6
3.7
ng/l
327.6
506.1
0.30
32
285
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
80
719
1.18
0.52
4.8
3.9
ng/l
41.6
54.9
0.64
67
549
(3022621) pH of Urine by Test strip
13
92
1.44
0.52
2.3
2.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
17
222
0.75
0.50
6.8
7.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
16
119
1.37
0.50
5.3
2.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
12
164
0.72
0.47
1.5
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
11
77
1.45
0.46
1.2
1.3
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
7
49
1.44
0.46
3.3
2.4
mmol/l
24.3
24.2
—
7
42
(3011397) Hemoglobin [Presence] in Urine by Test strip
37
313
1.22
0.46
3.8
3.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
45
391
1.19
0.43
4.9
3.3
estimate
0.0
0.0
0.50
15
109
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
31
1.63
0.43
1.0
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
32
271
1.21
0.40
22.0
30.1
inr
1.2
1.4
—
6
32
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
18
0.00
0.40
0.0
3.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
33
281
1.21
0.39
7.1
4.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
19
0.00
0.39
0.0
1.3
—
8.0
—
0
11
(3007164) IgA [Mass/volume] in Serum or Plasma
26
216
1.23
0.39
2.2
1.2
g/l
3.2
3.0
0.10
18
139
(4010399)
8
113
0.70
0.38
1.5
1.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
79
0.62
0.36
1.8
1.7
—
—
—
0
0
(3010421) pH of Blood
6
43
1.41
0.35
12.2
4.5
ph
7.4
7.4
—
6
33
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
44
1.37
0.34
1.5
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
93
992
0.89
0.33
3.1
2.9
pmol/l
14.2
15.1
3.10
82
873
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
55
499
1.14
0.31
2.7
2.1
nmol/l
71.2
75.1
0.59
46
435
(3019832) Treponema pallidum Ab [Presence] in Serum
7
53
1.33
0.31
1.1
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
144
1487
0.91
0.25
4.5
4.2
mmol/l
1.5
1.3
2.24
125
1336
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
149
1534
0.91
0.23
4.9
4.8
mmol/l
4.4
4.3
0.39
130
1392
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
5
38
1.32
0.23
4.6
1.3
g/l
0.0
0.0
—
5
33
(3052851) Hemolysis interference index of Serum or Plasma
5
40
1.26
0.22
6.4
3.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
10
124
0.80
0.22
1.4
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
127
1314
0.92
0.21
3.7
3.7
mu/l
2.0
2.0
0.04
107
1162
(4094501)
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
0
11
0.00
0.21
0.0
1.1
—
27.9
—
0
11
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
12
0.00
0.21
0.0
1.7
—
3.8
—
0
12
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
43
1.17
0.21
6.4
2.8
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.0
—
29.7
—
0
9
(3019060) Gas panel - Arterial blood
11
133
0.82
0.20
6.0
4.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
149
1524
0.93
0.16
4.4
4.7
mmol/l
1.2
1.3
1.66
128
1375
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
155
1516
1.08
0.16
4.7
4.9
mmol/l
6.2
6.2
0.19
139
1350
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
11
93
1.19
0.15
3.8
2.3
%
1.1
1.2
0.08
11
93
(3012516) Albumin [Mass/volume] in Urine
52
549
0.93
0.14
4.4
3.4
mg/l
139.0
257.5
0.39
39
375
(3009508) Creatinine [Moles/volume] in Urine
54
569
0.93
0.14
4.3
3.2
mmol/l
7.8
8.6
0.51
45
476
(3021447) Carbon dioxide [Partial pressure] in Venous blood
20
180
1.12
0.13
5.3
3.4
kpa
6.2
5.8
1.18
20
172
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
13
113
1.16
0.13
2.0
2.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
56
588
0.94
0.13
5.4
4.1
mg/mmol
20.6
10.3
0.69
43
399
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
5
44
1.14
0.10
4.6
1.3
g/l
0.0
0.0
—
5
39
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
5
48
1.04
0.09
4.6
1.2
g/l
36.9
37.5
—
5
36
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
101
987
1.04
0.09
5.9
3.7
%
20.2
24.3
1.66
53
465
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
74
1.08
0.07
1.4
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
10
111
0.90
0.06
1.9
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
145
1466
0.97
0.05
6.6
6.7
mmol/mol
41.6
41.3
0.15
125
1339
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
70
687
1.03
0.04
3.4
2.6
ug/l
1.1
0.8
0.49
46
454
(3024354) Oxygen [Partial pressure] in Venous blood
15
151
0.99
0.00
5.3
2.7
kpa
5.7
4.6
0.53
15
142
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
38
375
1.02
0.00
2.0
1.7
mmol/l
1.7
1.4
0.98
30
306
(1002224) Polysomnography panel
6
64
0.94
0.00
1.0
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
63
0.95
0.00
4.0
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
6
0.00
0.00
0.0
1.3
—
9.9
—
0
6
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
183.2
—
0
6
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020891) Body temperature
8
87
0.92
0.00
2.9
3.7
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
8.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
9.5
—
0.5
—
0
6
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
98.2
—
0
5
(3029075) Extractable nuclear Ab panel - Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
9
90
1.00
0.00
2.1
2.4
—
18.4
—
0
5
(44806420)
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
6
0.00
0.00
0.0
2.3
—
12.9
—
0
6
(3006462) Nitrate [Presence] in Urine
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(4133840)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
9
0.00
-0.00
0.0
11.2
—
1596.6
—
0
9
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
9
0.00
-0.00
0.0
9.8
—
1035.4
—
0
9
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_PENIS_EXALLC – Malignant neoplasm of penis, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).